Literature DB >> 23715576

Prediction of response to anticancer immunotherapy using gene signatures.

Ena Wang, Davide Bedognetti, Francesco M Marincola.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23715576     DOI： 10.1200/JCO.2013.49.2157

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  25 in total

1.  Inhibition of tumor growth and metastasis by EMMPRIN multiple antigenic peptide (MAP) vaccination is mediated by immune modulation.

Authors:  Elina Simanovich; Vera Brod; Maya M Rahat; Ella Drazdov; Miriam Walter; Jivan Shakya; Michal A Rahat
Journal:  Oncoimmunology       Date:  2016-11-29       Impact factor: 8.110

Review 2.  CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.

Authors:  Ryuma Tokunaga; Wu Zhang; Madiha Naseem; Alberto Puccini; Martin D Berger; Shivani Soni; Michelle McSkane; Hideo Baba; Heinz-Josef Lenz
Journal:  Cancer Treat Rev       Date:  2017-11-26       Impact factor: 12.111

Review 3.  Checkpoint Inhibitors and Their Application in Breast Cancer.

Authors:  Davide Bedognetti; Cristina Maccalli; Salha B J Al Bader; Francesco M Marincola; Barbara Seliger
Journal:  Breast Care (Basel)       Date:  2016-04-26       Impact factor: 2.860

4.  Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy.

Authors:  Daniel H Sterman; Evan Alley; James P Stevenson; Joseph Friedberg; Susan Metzger; Adri Recio; Edmund K Moon; Andrew R Haas; Anil Vachani; Sharyn I Katz; Jing Sun; Daniel F Heitjan; Wei-Ting Hwang; Leslie Litzky; Jennifer H Yearley; Kay See Tan; Emmanouil Papasavvas; Paul Kennedy; Luis J Montaner; Keith A Cengel; Charles B Simone; Melissa Culligan; Corey J Langer; Steven M Albelda
Journal:  Clin Cancer Res       Date:  2016-03-11       Impact factor: 12.531

Review 5.  Peptide-based vaccines for cancer therapy.

Authors:  Giorgio Parmiani; Vincenzo Russo; Cristina Maccalli; Danilo Parolini; Nathalie Rizzo; Michele Maio
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness.

Authors:  Lance D Miller; Jeff A Chou; Michael A Black; Cristin Print; Julia Chifman; Angela Alistar; Thomas Putti; Xiaobo Zhou; Davide Bedognetti; Wouter Hendrickx; Ashok Pullikuth; Jonathan Rennhack; Eran R Andrechek; Sandra Demaria; Ena Wang; Francesco M Marincola
Journal:  Cancer Immunol Res       Date:  2016-04-28       Impact factor: 11.151

7.  Network-based identification of key master regulators associated with an immune-silent cancer phenotype.

Authors:  Raghvendra Mall; Mohamad Saad; Jessica Roelands; Darawan Rinchai; Khalid Kunji; Hossam Almeer; Wouter Hendrickx; Francesco M Marincola; Michele Ceccarelli; Davide Bedognetti
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 11.622

8.  CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2.

Authors:  D Bedognetti; T L Spivey; Y Zhao; L Uccellini; S Tomei; M E Dudley; M L Ascierto; V De Giorgi; Q Liu; L G Delogu; M Sommariva; M R Sertoli; R Simon; E Wang; S A Rosenberg; F M Marincola
Journal:  Br J Cancer       Date:  2013-10-15       Impact factor: 7.640

9.  The immune-related role of BRAF in melanoma.

Authors:  Sara Tomei; Davide Bedognetti; Valeria De Giorgi; Michele Sommariva; Sara Civini; Jennifer Reinboth; Muna Al Hashmi; Maria Libera Ascierto; Qiuzhen Liu; Ben D Ayotte; Andrea Worschech; Lorenzo Uccellini; Paolo A Ascierto; David Stroncek; Giuseppe Palmieri; Lotfi Chouchane; Ena Wang; Francesco M Marincola
Journal:  Mol Oncol       Date:  2014-08-06       Impact factor: 6.603

10.  Direct T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme.

Authors:  P Jin; S Civini; Y Zhao; V De Giorgi; J Ren; M Sabatino; J Jin; H Wang; D Bedognetti; F Marincola; D Stroncek
Journal:  Br J Cancer       Date:  2014-05-08       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.